IP Library › Assignment 035453/0224
Patent Assignment
Reel/Frame 035453/0224

Assignment of Assignor's Interest

Recorded: 2015-04-16 Pages: 10
Assignor
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties (64)
Hedgehog Pathway Modulators
Patent: 9,216,964 →
Application: 13/937,477 →
Publication: US US20130296333A1
Compounds and Compositions as Protein Kinase Inhibitors
Application: 14/574,063 →
Publication: US US20150105390A1
Biosynthetically Generated Pyrroline-Carboxy-Lysine and Site Specific Protein Modifications via Chemical Derivatization of Pyrroline-Carboxy-Lysine and Pyrrolysine Residues
Patent: 9,624,520 →
Application: 14/279,085 →
Publication: US US20140302553A1
N-(Hetero)Aryl, 2-(Hetero)Aryl-Substituted Acetamides for Use as Wnt Signaling Modulators
Patent: 9,238,646 →
Application: 13/948,038 →
Publication: US US20130310375A1
Compounds and Compositions for the Treatment of Parasitic Diseases
Patent: 9,469,645 →
Application: 13/912,898 →
Publication: US US20130281403A1
N-(Pyridin-2-Yl)Sulfonamides and Compositions Thereof as Protein Kinase Inhibitors
Patent: 9,181,238 →
Application: 13/577,209 →
Publication: US US20130143899A1
Compounds and Compositions as TLR2 Agonists
Patent: 9,365,506 →
Application: 14/326,957 →
Publication: US US20140323390A1
Compositions and Methods for Modulating Fxr
Patent: 9,150,568 →
Application: 13/993,138 →
Publication: US US20130331349A1
Compounds and Compositions as Trk Inhibitors
Patent: 9,102,671 →
Application: 14/000,578 →
Publication: US US20130331397A1
Compounds and Compositions as C-Kit Kinase Inhibitors
Patent: 9,199,981 →
Application: 13/595,575 →
Publication: US US20130059846A1
Compounds and Compositions as C-Kit Kinase Inhibitors
Patent: 9,023,839 →
Application: 14/258,963 →
Publication: US US20140228347A1
Compounds and Compositions for Modulating EGFR Activity
Patent: 9,440,957 →
Application: 14/405,773 →
Publication: US US20150197505A1
Compounds and Compositions for Modulating EGFR Activity
Application: 14/405,694 →
Publication: US US20150152083A1
Site-Specific Labeling Methods and Molecules Produced Thereby
Patent: 9,585,970 →
Application: 13/906,584 →
Publication: US US20140065171A1
Site-Specific Labeling Methods and Molecules Produced Thereby
Application: 14/402,808 →
Publication: US US20150104468A1
Compounds and Compositions for the Treatment of Parasitic Diseases
Patent: 9,186,361 →
Application: 14/209,655 →
Publication: US US20140274926A1
Peptides and Compositions for Treatment of Joint Damage
Patent: 9,301,971 →
Application: 14/201,694 →
Publication: US US20140256643A1
Compounds and Compositions for the Treatment of Parasitic Diseases
Patent: 9,303,034 →
Application: 14/574,775 →
Publication: US US20150175613A1
Specific Sites for Modifying Antibodies to Make Immunoconjugates
Application: 61/952,026 →
Compounds and Compositions as Toll-Like Receptor 7 Agonists
Application: 61/987,314 →
Compounds and Compositions as Toll-Like Receptor 7 Agonists
Application: 61/987,321 →
Specimen Plate Lid and Method of Using
Patent: 6,534,014 →
Application: 09/569,325 →
High Throughput Processing System and Method of Using
Patent: 7,390,458 →
Application: 09/981,313 →
Publication: US US20020090320A1
Multi-Sample Fermentor and Method of Using Same
Patent: 6,723,555 →
Application: 10/071,842 →
Publication: US US20020146818A1
Multi-Sample Fermentor and Method of Using Same
Patent: 6,635,441 →
Application: 09/780,591 →
Publication: US US20030157591A1
Gripping Mechanisms, Apparatus, and Methods
Patent: 6,932,557 →
Application: 10/620,324 →
Publication: US US20040086368A1
Gripping Mechanisms, Apparatus and Methods
Patent: 7,422,411 →
Application: 11/516,826 →
Publication: US US20070005182A1
Gripper Mechanism
Patent: 6,592,324 →
Application: 09/793,254 →
Publication: US US20020117380A1
High Throughput Incubation Devices
Patent: 7,329,394 →
Application: 10/200,021 →
Publication: US US20030031602A1
Nucleoside Analog Libraries
Patent: 7,034,147 →
Application: 10/379,607 →
Publication: US US20030225205A1
Methods and Compositions for Inducing Apoptosis in Cancer Cells
Patent: 7,229,617 →
Application: 10/723,383 →
Publication: US US20050079172A1
Methods and Compositions for Inducing Apoptosis in Cancer Cells with an Anti-DR5 Antibody
Patent: 8,173,128 →
Application: 11/607,208 →
Publication: US US20070128204A1
Universal G-Protein Coupled Receptor Reporter Constructs
Patent: 7,229,768 →
Application: 10/759,740 →
Publication: US US20050158813A1
Substituted Pyrrolo[2,3-2]Pyrimidines as Protein Kinase Inhibitors
Patent: 7,968,557 →
Application: 10/589,099 →
Publication: US US20070225306A1
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 7,745,437 →
Application: 11/628,881 →
Publication: US US20070225286A1
Compounds and Compositions as Modulators of GPR119 Activity
Patent: 8,153,635 →
Application: 12/204,600 →
Publication: US US20090270409A1
Compounds and Methods for Modulating G Protein-Coupled Receptors
Patent: 8,362,050 →
Application: 12/999,887 →
Publication: US US20110172278A1
Compounds and Compositions as Hedgehog Pathway Inhibitors
Patent: 8,507,491 →
Application: 13/060,426 →
Publication: US US20110152282A1
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,399,450 →
Application: 13/172,357 →
Publication: US US20110257154A1
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,377,921 →
Application: 13/172,572 →
Publication: US US20110257155A1
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,372,858 →
Application: 13/048,636 →
Publication: US US20110190259A1
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,957,081 →
Application: 13/610,422 →
Publication: US US20130005748A1
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,039,479 →
Application: 11/943,436 →
Publication: US US20080176881A1
Compounds and Compositions as Hedgehog Pathway Modulators
Patent: 8,178,563 →
Application: 12/299,290 →
Publication: US US20090203666A1
Fused Nitrogen Containing Heterocycles and Compositions Thereof as Kinase Inhibitors
Patent: 8,507,488 →
Application: 12/992,027 →
Publication: US US20110166133A1
Anti-Trkb Antibodies
Patent: 8,642,035 →
Application: 12/864,636 →
Publication: US US20110097326A1
Azolopyrimidines as Inhibitors of Cannabinoid 1 Activity
Patent: 8,722,691 →
Application: 12/295,555 →
Publication: US US20090247556A1
5- (4- (Haloalkoxy) Phenyl) Pyrimidine-2-Amine Compounds and Compositions as Kinase Inhibitors
Patent: 8,293,757 →
Application: 12/674,416 →
Publication: US US20110301175A1
Biosynthetically Generated Pyrroline-Carboxy-Lysine and Site Specific Protein Modifications via Chemical Derivatization of Pyrroline-Carboxy-Lysine and Pyrrolysine Residues
Patent: 8,785,151 →
Application: 13/125,547 →
Publication: US US20110262963A1
N- (Hetero)Aryl, 2- (Hetero)Aryl-Substituted Acetamides for Use as Wnt Signaling Modulators
Patent: 8,546,396 →
Application: 13/132,294 →
Publication: US US20110237573A1
Compounds and Compositions Useful for the Treatment of Parasitic Diseases
Patent: 8,557,801 →
Application: 12/833,909 →
Publication: US US20110059934A1
Compounds (Cystein Based Lipopeptides) and Compositions as TLR2 Agonists Used for Treating Infections, Inflammations, Respiratory Diseases Etc.
Patent: 8,808,703 →
Application: 13/636,328 →
Publication: US US20130065861A1
Methods of Using Alk Inhibitors
Patent: 8,703,787 →
Application: 13/981,046 →
Publication: US US20130296357A1
Compounds and Compositions as C-Kit Kinase Inhibitors
Patent: 8,754,071 →
Application: 14/031,792 →
Publication: US US20140031333A1
Compounds and Compositions as C-Kit Kinase Inhibitors
Patent: 8,569,283 →
Application: 13/598,213 →
Publication: US US20130059832A1
Compounds and Compositions for the Treatment of Parasitic Diseases
Compounds and Compositions for the Treatment of Parasitic Diseases
Specific Sites for Modifying Antibodies to Make Immunoconjugates
Specific Sites for Modifying Antibodies to Make Immunoconjugates
Peptides and Compositions for Treatment of Joint Damage
Compositions and Methods for Modulating Farnesoid X Receptors
Combination Therapy
Compounds and Compositions for the Treatment of Parasitic Diseases
Cytotoxic Peptides and Conjugates Thereof
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 7, 2013
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC.
To: IRM, LLC
Reel/Frame 030960/0237 →
Assignment of Assignor's Interest Aug 7, 2013
From: GEIERSTANGER, BERNARD HUBERT; GRUNEWALD, JAN; BURSULAYA, BADRY
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC.
Reel/Frame 030960/0001 →
Assignment of Assignor's Interest Dec 3, 2014
From: GEIERSTANGER, BERNHARD HUBERT; GRUNEWALD, JAN; BURSULAYA, BADRY
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION (GNF)
Reel/Frame 034360/0472 →
Assignment of Assignor's Interest Dec 3, 2014
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION (GNF)
To: IRM LLC
Reel/Frame 034361/0883 →
Assignment of Assignor's Interest Jan 9, 2015
From: PETRASSI, HANK MICHAEL JAMES; LIU, XIAODONG; LOREN, JON; MOLTENI, VALENTINA
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS
Reel/Frame 034676/0561 →
Assignment of Assignor's Interest Jan 13, 2015
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
To: IRM LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 034692/0709 →
Assignment of Assignor's Interest Jan 15, 2015
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
To: IRM LLC
Reel/Frame 034730/0558 →
Assignment of Assignor's Interest Jan 15, 2015
From: CHATTERJEE, ARNAB KUMAR; LIANG, FANG; MATHISON, CASEY JACOB NELSON; MOLTENI, VALENTINA
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
Reel/Frame 034729/0886 →
Assignment of Assignor's Interest Apr 3, 2015
From: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
To: NOVARTIS AG
Reel/Frame 035328/0948 →
Merger Apr 3, 2015
From: IRM LLC
To: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
Reel/Frame 035327/0371 →
Merger Apr 16, 2015
From: IRM LLC
To: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
Reel/Frame 035444/0397 →
Merger Apr 16, 2015
From: IRM LLC
To: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
Reel/Frame 035427/0846 →
Assignment of Assignor's Interest Jun 23, 2015
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC, DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
To: IRM LLC
Reel/Frame 035882/0566 →
Assignment of Assignor's Interest Jun 23, 2015
From: FAN, YI; LOREN, JON; MOLTENI, VALENTINA; SMITH, JEFFREY M
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC
Reel/Frame 035961/0408 →
Assignment of Assignor's Interest Jun 24, 2015
From: YEH, VINCE; LIU, XIAODONG; LOREN, JON; MOLTENI, VALENTINA
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION,
Reel/Frame 036013/0364 →
Assignment of Assignor's Interest Jun 24, 2015
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
To: IRM LLC
Reel/Frame 035896/0921 →
Assignment of Assignor's Interest Jul 24, 2015
From: TELLEW, JOHN; PAN, SHIFANG; WAN, YONGQIN; XIE, YONGPING
To: IRM LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 036174/0685 →
Assignment of Assignor's Interest Jul 24, 2015
From: ZHANG, QIONG
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 036174/0723 →
Corrective Assignment to Correct the Spelling of Assignor Name (Correct: Pan, Shifeng) Previously Recorded on Reel 036174 Frame 0685. Assignor(S) Hereby Confirms the Assignment. Aug 3, 2015
From: TELLEW, JOHN; PAN, SHIFENG; WAN, YONGQIN; XIE, YONGPING
To: IRM LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 036252/0714 →
Assignment of Assignor's Interest Aug 26, 2015
From: CHENG, DAI; HAN, DONG; ZHANG, GUOBAO; WAN, YONGQIN
To: IRM LLC
Reel/Frame 036426/0616 →
Assignment of Assignor's Interest Oct 30, 2015
From: BIGGART, AGNES; LIANG, FANG; MATHISON, CASEY JACOB NELSON; MOLTENI, VALENTINA
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
Reel/Frame 036923/0269 →
Assignment of Assignor's Interest Oct 30, 2015
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA THE GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
To: IRM LLC
Reel/Frame 036923/0547 →
Assignment of Assignor's Interest Nov 17, 2015
From: CHENG, DAI; ZHANG, GUOBAO; HAN, DONG; PAN, SHIFENG
To: IRM LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 037060/0863 →
Assignment of Assignor's Interest Dec 3, 2015
From: CHATTERJEE, ARNAB; NAGLE, ADVAIT S.; WU, TAO; TULLY, DAVID C.
To: IRM LLC
Reel/Frame 037205/0776 →
Assignment of Assignor's Interest May 6, 2016
From: WU, TOM YAO-HSIANG; ZOU, YEFEN; HOFFMAN, TIMOTHY Z.; PAN, JIANFENG
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC.
Reel/Frame 038489/0901 →